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1. Introduction 
There is an old dispute what is more valuable in work of atomic power stations - the electric 
power or by-products of its operation - produced stable and radioactive isotopes. Among 
the experts in reactors physics and techniques, an opinion prevails that nuclear reactors 
make profit exclusively from electric power production on atomic power stations. However 
some specialists consider this opinion rather far from a real state of things.  
In the early nineties on the initiative of the American Council for Energy Awareness, 
USCEA, detailed research of influence of nuclear and radiating technologies (except for 
defensive) on national economy of the USA (Rabotnov, 1999) was undertaken. It consisted of 
two parts. In one part applications of radioactive materials in the industry, medicine and 
scientific researches were only considered, in the other - actually nuclear power, that is 
electric power production at atomic power stations. Results have surprised both authors of 
the report, and customers. First, the scale of figures. It appeared, that the total annual 
volume of the business connected with radioisotopes application in the United States made 
257 billion dollars in 1991. Secondly, this sum appeared three and a half times more than the 
full cost of the nuclear electric power (73 billion dollars). Radioisotopes are used in eight 
various branches, 3.7 million persons of almost five hundred specialties are employed in this 
activity that makes about three percent of full employment in the USA. The total product of 
330 billion dollars means that the nuclear-power and radiation complex of the USA looks as 
the eleventh on size a world industrial state. 
Actually nuclear reactors are “generators” of a large amount of artificial radioisotopes, basic 
of which are fission products and actinium series. It is assumed to consider as fission 
products not only the radioisotopes got directly as a result of heavy nuclei fissions, but also 
the radioisotopes formed as a result of radioactive transformations and nuclear reactions of 
type (n, Ǆ), (n, 2n), (n, p), etc. on radioactive and stable nuclei of fission products. 
The chapter presents low-waste technologies of medical fragment radioisotopes production. 
Schemes of fragment radioisotopes production in reactors with fuel in the form of uranium 
salts solution or with molten-salt fuel on the basis of metal fluorides LiF, BeF2, UF4 are 
considered. The aggregate state of liquid fuel opens the possibility of selective extraction of 
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fragment radioisotopes 99Mo/99m Tc, 89Sr, 131,133I, 133Xe, etc. from fuel not involving both 235U 
and the basic group of fragment elements. Radiochemical processing of the irradiated 
uranium typical for solid fuel systems is as a result excluded, that finally should lead to 
decrease in an exit of a highly active waste and reduction of the fission materials flow in 
technological process. 
2. Application of fragment radioisotopes in medicine 
One of the most scale consumers of radioisotopes is nuclear medicine where they are 
applied in diagnostics and therapy of heavy diseases. Production of medical radioisotopes 
has turned to an important branch of the industry sharing more than 50 % of annual 
radioisotopes production all over the world. Today more than 160 radioisotopes of 80 
chemical elements are produced by means of nuclear reactors and charged particles 
accelerators. The nomenclature of preparations labeled with radioisotopes permanently 
extends, new diagnostic instruments are developed. High efficiency of radioisotopes use in 
medicine is confirmed by long-term clinical practice. Radioisotope methods are used in 
oncology, cardiology, hematology, urology, nephrology, etc. 
The simplest and cheapest way of scale radioisotopes production is based on fission reaction 
(n,f). The basic medicine radioisotopes formed as a result of uranium-235 fission by 
neutrons are 137Cs, 131I, 133Xe, 90Sr and 99Mo. 
99Mo is one of the most demanded radioisotopes in nuclear medicine. It is used in 
99Mo/99mTc generators widely applied in the world at early diagnostics of oncologic, 
cardiovascular and a number of other diseases. More than 80 % of radiodiagnostic 
procedures in the world are carried out by preparations labeled with 99mТc (IAEA, 1999). 
From the IAEA data, approximately 15 millions of diagnostic procedures were carried out 
with 99mTc annually in the world ten years ago, from them 7 millions in Europe and 8 
millions in the USA. The total world consumption of 99Mo/99mTc for that period was 
estimated at a level of 6 000 Ci a week (6 day pre-calibration). The prediction of 99Mo 
demand till 2006 made in works (Ball, 1999; Ball, Nordyke  & Brown, 2002) is illustrated in 
the diagram in figure 1. About 30 millions of diagnostic procedures are carried out with 
99mTc in the world annually today (Hansell, 2008). The world consumption of 99Mo/99mTc 
has exceeded 12 000 Ci a week, and annual volume of the world market of 99mTc 
consumption is estimated as US$ 3.7 billion (including cost of medical services).  
The basic producers of 99Mo are Canada, EU and South Africa, which supply about 95 % of 
this radioisotope in the world. The technology of 99Mo production is based on irradiation in 
research reactors and subsequent radiochemical processing of the targets from highly-
enriched uranium. Table 1 provides further information on the major 99Mo producing 
reactors (Westmacott, 2010). 
Recent series of the not planned stops of the reactors producing 99Mo, mainly due to 
significant age of these reactors, have shown to the world imperfection of the existing 
system of supplying this radioisotope and have caused growing concern for the future of 
nuclear medicine. The faults in 99Mo production had negative effect on treatment of 
oncologic patients in Europe and Northern America. For example, during these stops, 
supply of 99Mo/99mTc generators in some British hospitals has reduced to 30 % from normal. 
The doctors had to choose, who from the patients more than others requires the procedures 
with 99mTc. 
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Reactor 
name 
Location 
Annual 
operating 
days 
Normal 
production 
per week1 
Weekly % 
of world 
demand 
Fuel/ 
Targets2 
Date of first 
commis-
sioning 
BR-2 Belgium 140 5 2003 25-65 HEU/HEU 1961 
HFR Netherlands 300 4 680 35-70 LEU/HEU 1961 
LVR-154 Czech Rep. - >600 - HEU5/HEU 1957 
MARIA4 Poland - 700-1 500 - HEU/HEU 1974 
NRU Canada 300 4 680 35-70 LEU/HEU 1957 
OPAL Australia 290 1 000-1 500 -6 LEU/LEU 2007 
OSIRIS France 180 1 200 10-20 LEU/HEU 1966 
SAFARI-1 South Africa 305 2 500 10-30 LEU/HEU7 1965 
RA-3 Argentina 230 200 <2 LEU/LEU 1967 
1. Six-day curies end of processing. In some cases, the maximum production can be substantially 
higher that the values listed here for normal production. 
2. Fuel elements and targets are classified as either LEU, containing less than 20% of 235U, or HEU, 
which contains greater than 20% 235U (in some cases greater than 95%). 
3. Does not account for increase in capacity since April 2010 with the installation of additional 
irradiation capacity. This increases BR-2 available capacity to approximately 7 800 six-day curies 
EOP: however it is not yet clear what “normal” production will be at the facility. 
4. These reactors started production in 2010, - so some data is not available yet. 
5. The LVR-15 reactor uses fuel elements that are enriched to 36% 235U. 
6. The OPAL reactor started production in 2007 for domestic use but has not yet exported significant 
amounts. 
7. SAFARl-1 is in the process of converting to using LEU targets and expects to have completed 
conversion in 2010. 
Table 1. Major 99Mo producing reactors  
An attempt to solve the problem of 99Mo production by building two specialized reactors 
MAPLE in Canada was not successful - May 16, 2008 these reactors were finally stopped 
because of the made design mistakes. Against steady ageing of the research reactors 
which operation time sometimes exceeds 50 years (reactor NRU), this problem becomes 
sharper. 
Besides, the isotope crisis has drawn attention to one more acute problem – production 
technology. The fission fragment method is a basis of current 99Mo production. A highly-
enriched uranium target is irradiated in a reactor, and then processed by one of the known 
radiochemical ways. 99Mo, which specific activity reaches several tens thousand Ci per gram 
of molybdenum is separated from fission products (Gerasimov, Kiselev & Lantcov, 1989). 
More than 95 % of 99Mo are produced using highly-enriched uranium (HEU), ~90 % of 235U. 
Commercial producers of 99Mo spend about 50 kg of HEU annually. 
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The weakest feature of this way of 99Mo production is extremely inefficient use of uranium. 
Only ≈0.4 % of 235U is used for production of 99Mo, and the other part is directed in waste. 
Moreover, at fission of uranium a wide spectrum of fragments is formed, which total activity 
at the moment of irradiation end exceeds activity of 99Mo by two orders of value. That results 
in necessity of contamination of plenty radioactive waste, including long-lived ones. 
 
Fig. 1. Prediction of growth of demand for 99Mo in the world (Ball, 1999; Ball, Nordyke  & 
Brown, 2002) 
In Fig. 2 the basic stages of the existing 99Mo production technology are shown - from 
manufacturing of a uranium target to delivering the final product to the consumer. 
 
Fig. 2. Basic stages of the existing 99Mo production technology 
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The third problem of the traditional 99Mo production is that its target waste can be easily 
transformed by known chemical methods to metal HEU - material used in manufacture of 
nuclear military loads. Orientation of modern 99Mo production on the use of highly-
enriched uranium, against gradual deducing of HEU from a civil turn according to the 
IAEA “non-proliferation” concept, creates additional risks for 99Mo consumers. Thereupon 
expected rapid development of the nuclear medicine using 235U fission products can lead the 
next years to serious problems with ensuring the efficiency of the international monitoring 
system for non-proliferation of nuclear materials.  
In the international community there is a consensus about necessity to limit or even to bring 
to naught HEU turn in the civil sphere. Programs, in particular, the program RERTR 
(Reduced Enrichment for Research and Test Reactors) on reduction of HEU turn in peace 
sectors of economy are accepted. The research reactors used for production of 99Mo will be 
gradually converted to low-enriched uranium fuel (LEU) and LEU-targets. Risks from use of 
uranium of high enrichment will start to constrain sooner or later, and then can even stop 
this production completely. 
The world crisis of 99Mo production gives an exclusive chance for realization of alternative 
methods of this radioisotope production, free from disadvantages of the modern 
technologies and ensuring large-scale low-waste production of 99Mo based on the use of 
low-enriched uranium. 
What could be alternative? The choice, in effect, is limited: building of a new multi-purpose 
research reactor, development of accelerating methods or building of inexpensive and 
simple in operation solution reactors. Taking into account inertia of the licensing system and 
time for designing and building the facilities, the choice needs to be made the next years.  
It would seem, the most real alternative to HEU for today is conversion of a research reactor 
core for work with LEU-fuel and introduction of new types of targets of low-enriched 
uranium. However the “target” technology characterized by the lowest efficiency of use of 
uranium, most likely will not give competitive advantages as the use of LEU will inevitably 
lead to involving for manufacture of a considerable amount of irradiated uranium. It will 
result in additional loadings on radiochemical processing and in considerable amount of 
radioactive waste that, obviously, will raise production cost price. The most research 
reactors now producing the basic amount of 99Mo are depreciated and for their maintenance 
in operating and safe condition more and more considerable efforts and expenses are 
required. The next years these reactors will demand capital reconstruction or will be 
deduced from operation.  Other alternative technologies based on neutron activation of 
molybdenum isotope 98Mo or on uranium photo-fission at accelerators, are not effective for 
large-scale production and can be applied only for satisfying regional needs. 
Renunciation of the traditional technology of uranium targets irradiation and transition to 
technologies based on specific physical-chemical properties of liquid nuclear fuel, ensuring 
an opportunity to extract 99Mo directly from the reactor fuel leaving uranium and fission 
fragments in it, allow to exclude a problem of highly-enriched uranium contamination and 
to simplify the problem of handling the radiochemical processing waste radically. Water 
solutions of uranium salts or melts of fluoride salts can be used as liquid nuclear fuel.  
The aggregate state of liquid fuel opens the possibility of selective extraction of fragment 
radioisotopes 99Mo/99m Tc, 89Sr, 131,133I, 133Xe, etc. from fuel not involving both 235U and the 
basic group of fragment elements. It will lead to sharp decrease in the flow of nuclear 
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materials in the technological process and in the yield of highly active waste. Estimations 
show, for example, that a solution reactor of 200 kW power is capable to produce more than 
1000 Ci/w of 99Mo with calibration for 6-days from the moment of delivery.  
The technology based on use of homogeneous liquid nuclear fuel possesses a number of 
obvious advantages in comparison with a “target” method:  
- All fuel of such a reactor is a “target”; 
- There is no necessity for creation of special facility for manufacturing and 
radiochemical processing of targets; 
- 99Mo is selectively taken from solution fuel by sorption on special filters or 
spontaneously leaves the molten salt fuel in the form of flying fluorides; 
- Uranium and the basic highly active fission fragments remain in fuel; 
- Reactors with homogeneous fuel possess immanent nuclear safety (negative thermal 
reactivity factor);  
- Research mini-reactor “Argus” with solution fuel in the form of UO2SO4 has operated in 
Russia for about 30 years;  
- Research reactor MSRE of power 8 MW with molten salt fluoride fuel LiF-BeF2-UF4 
successfully operated in the USA within four years,  when the effect of spontaneous exit 
of a part of fission fragments in the gas phase was observed (including 99Mo);  
- There are no problems with reactor operation on LEU.  
Now development and creation of a specialized nuclear-chemical complex for commercial 
production of fragment radioisotopes 99Mo, 89Sr, 133Xe, 131I, 133I, etc. for satisfaction of 
growing requirements of nuclear medicine look actual. 
3. Production of fragment radioisotopes with help of molten salt fluoride 
nuclear fuel  
Transition from the traditional technology of uranium targets irradiation to the technology 
based on an unique effect of spontaneous exit of fragment 99Mo from molten salt fluoride 
fuel to the gas phase (Grimes, 1970), observed in the late sixties in the experimental reactor 
MSRE (ORNL) allows to simplify a problem of waste disposal at production of fragment 
radioisotopes considerably. According to the results of measurements, more than 50 % of all 
molybdenum formed at fission of uranium leaves melts. The most of other fragment 
elements, such as Zr, Ba, Sr, Cs, Br, I, rare-earth elements and all uranium having steady 
well soluble in fuel salt compounds remain in melts. 
The idea of use of molten salt nuclear fuel in the reactor technology was proposed at the 
beginning of the 50-ties at creation of small power autonomous energy sources. A distinctive 
feature of this kind of fuel is the possibility of continuous correction of the chemical 
structure and control of nuclear-physical, chemical and thermal processes at its work in the 
nuclear reactor.  
The molten salt reactor concept was realized at creation of experimental reactors ARE 
(Aircraft Reactor Experiment) by power of 2.5 MW and MSRE (Molten-Salt Reactor 
Experiment) of 7.3 MW. The first experimental molten salt reactor, ARE, constructed in the 
USA in 1954, worked with salt composition NaF-ZrF4-UF4 at temperature 860oC (Bettis e.a., 
1957). The basic task of the experiment was confirmation of serviceability and stability of the 
reactor with circulating fuel. MSRE operated in Oak Ridge National Laboratory (ORNL) 
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within four years in the late 60s (Haubenreich & Engel, 1970) with fuel 7LiF-BeF2-ZrF4-UF4 at 
temperature 650oC. The purposes of MSRE construction consisted in working out the molten 
salt nuclear fuel technology, checking the serviceability of some structure units, study of 
neutronics characteristics of this reactor type. Corrosion steady nickel alloy Hastelloy-N was 
developed, some questions of processing and cleaning the salt were solved during reactor 
operation, and its nuclear safety was shown.  
Significant researches of molten salt coolants were performed in the Soviet Union (Novikov 
et al., 1990). The structural materials on the basis of nickel, corrosion stable in fluorides are 
created, the pump, heat exchanging devices of various purposes etc are developed and 
checked in conditions of stand tests. Now these researches proceed, mainly within the 
framework of the international project “Generation-IV” on creation of new generation 
nuclear reactors.  
3.1 Behavior of fission fragments in molten salt fuel 
In MSRE, the basic group of fragment elements, such as Zr, Ba, Sr, Cs, Br, I and rare earth 
elements, having well soluble in salt compounds remained in fuel. Insoluble compounds 
deposited on the surface of structural materials of the reactor facility (graphite, Hastelloy-
N). Krypton and xenon, having low solubility in salt, spontaneously or under bubbling of 
fuel by inert gas left the salt melt. Moreover it was found, that a small group of elements, so-
called “noble” metals Mo, Nb, Te, Ru in the form of volatile fluorides or aerosols entered gas 
covering free surfaces of salt. About half of these elements deposited on surfaces of reactor 
structural materials and less than 1% remained in fuel salt.  
In a series of ORNL 1966-1970 reports the results of numerous measurements of fuel 
structure, researches of structural material samples and gas tests from MSRE contour are 
published. An analysis of these experimental data has allowed us to reveal certain laws of 
distribution of some fragment elements in the reactor facility, to put forward a hypothesis of 
the mechanism of “noble” metals exit to gas volume above the salt melt and on this basis to 
propose a new way of fragment 99Mo production. 
In particular, in (Rosenthal et al., 1969) (see tab. 2) the balance of radionuclides in reactor 
MSRE is shown. Significant fraction of 99Mo, 132Te, 103Ru entered gas covering free surfaces 
of salt. The detection of significant amount of 89Sr in the gas volume above the salt surface is 
connected with its predecessor 89Kr entering into gas. 
  
Nuclide 
Contents (% from calculated value) 
Fuel Graphite Hastelloy-N 
Evacuated 
gases 
Total yield 
99Mo 
132Te 
129Te 
103Ru 
95Nb 
89Sr 
0.17 
0.47 
0.40 
0.033 
0.001 
83 
9.0 
5.1 
5.6 
3.5 
41 
17 
28 
14 
17 
3.7 
18 
8.5 
50 
74 
31 
49 
11 
0.11 
87 
94 
54 
56 
70 
109 
Table 2. Distribution of fission products in reactor MSRE 
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The assumption was made, that these fission fragments arising in extremely electron-scarce 
states, in the process of their thermalization catch electrons, passing a number of unstable, 
but volatile valent states (Kirslis & Blankenship, 1967). If the reactor structural materials are 
rather inert, and the fuel does not contain significant amount of other absorbers of radiolytic 
fluoride, some part of Mo, Te and Ru will oxide up to maximal fluorides and pass to the gas 
phase. 
In work (Rosenthal et al., 1968), 50 g salt samples were located in hermetic reactionary 
volumes connected to a gas contour, from which helium or mix of helium with hydrogen 
could be made to fuel melt. For melting of fuel the reactionary volume was heated up to 
600oC. The gas moved in the tube at the flow rate 10 - 15 cm3⋅min-1, allowing both blowing 
the salt melt mirror and bubbling the fuel. After passage of reactionary volume the gas was 
evacuated through a system of filters including few sections of fission fragments catching – 
metal-ceramic filter, sorbent on the basis of NaF and chemical sorbent. After reactor 
operation of 32 000 MW×h the filters were removed, each section was separately dissolved 
in acid and the solutions were analyzed on the contents of fission fragments and 235U. Some 
measurement results of the salt radioisotope structure are given in table 3.  
Calculated by us total activities of radioisotopes collected in all elements of filtration system, 
normalized to initial activity in salt test are shown in the same table. The cumulative yields 
of radioisotopes at 235U fission by thermal neutrons, their half-decay periods, chemical 
formulas of maximal fluorides of elements and boiling temperatures of these chemical 
compounds are also shown here.  
 
Parameter 103Ru 132Te 95Nb 99Mo 95Zr 144Ce 140Ba 
Т1/2 39.36 
days 
78.2 
h 
34.97 
days 
66.0 
h 
64.02 
days 
284.4 
days 
12.75 
days 
Cumulative yield of 
nuclide at fission of 
235U,% 
3.04 4.28 6.5 6.15 6.29 5.47 6.08 
Cross section of the 
reaction (n,γ), barn 7.71  <7 1.73 0.49 2.6 1.6 
Nuclide specific 
activity in melt, 
decay⋅min-1⋅g-1 
7.5⋅106 1.7⋅108 109 1.2⋅109 1.2⋅1011 7.3⋅1010 1.6⋅1011 
Nuclide concentration 
in melt, g-1 
6.1⋅1011 1.2⋅1012 7.3⋅1013 6.8⋅1012 1.6⋅1016 4.3⋅1016 4.2⋅1015 
Ratio of total nuclide 
activity in filters to its 
activity in 1 g of initial 
melt, rel. un. 
5.6 0.7 ≈0.02 1.1 1.1⋅10-4 2.0⋅10-5 1.2⋅10-5 
Maximal fluorides of 
nuclides 
RuF5 TeF6 NbF5 MoF6 ZrF4 CeF3 BaF2 
Boiling temperature of 
maximal fluorides at 
saturated vapor 
pressure 760 mm, 0ǿ 
272 -38.9 233 36.2 903 2327 2260 
Table 3. Radioisotope structure of MSRE fuel (“blowing” of a salt mirror with helium) 
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First of all one may indicate a wide scatter of fission fragments concentrations in the initial 
salt sample and a possibility to divide them into two groups by this parameter. The 
concentrations of 99Mo, 132Te, 95Nb, 103Ru are lower by two - four orders of value than the 
concentrations of 89Sr, 141,144Ce, 95Zr, 140Ba, though cumulative yields of these fragments 
differ not more than twice. It is impossible to explain the so large difference by burning up 
of fragments in the reactor, at the given cross sections. The most probable reason is 
connected to individual behavior of chemical compounds of these elements in molten salt 
fuel.  
In table 3 there are two radioisotopes 95Nb and 95Zr presenting the generically connected 
pair in the decay 95Kr→95Rb→95Sr→95Y→95Zr→95Nb→95Mo. At long irradiation of fuel, these 
radioisotopes should be in balance, i.e. their activities should be equal. The difference of 
95Nb and 95Zr activities by more than two orders of value means, that 95Nb mainly leaves 
melt, and 95Zr remains in fuel.  
The observable difference in concentrations of the two groups of radioisotopes specified in 
table 3 can be explained by exit of 99Mo, 132Te, 95Nb, 103Ru to the gas phase in form of volatile 
fluorides, boiling temperature of which is much lower than the temperature of salt melt. 
Thus refractory fluorides 95Zr, 141,144Ce, 140Ba mainly remain in salt.  
Molybdenum has a few stable fluorides, which can be formed under Ǆ-irradiation of the 
nuclear reactor - MoF3, MoF4, MoF5, MoF6. At the fuel melt temperature ≈6000C,  significant 
fractions of tetra- and pentafluoride of molybdenum MoF4, MoF5 and also molybdenum 
hexafluoride MoF6 (boiling temperature of 36.20ǿ (Nikolsky, 1998) are in the gas phase. In 
case these compounds arise near to borders with the gas phase, they can leave the melt. 
In work (Kirslis & Blankenship, 1969), the degree of fission fragments penetration in 
graphite of MSRE core was investigated. As well as for the previous experiment, we were 
interested by penetration into graphite of generically connected pair 95Zr→95Nb. It follows 
from experimental data that 95Nb concentration in graphite has appeared approximately by 
three orders of value higher, than 95Zr. Their distribution on depth of the graphite sample is 
shown in figure 3. 
It is known, that the radioactive atoms formed as a result of nuclear transformations, 
partially appear in chemical compound, at which they were formed, as so-called “parent” 
compound (Nesmeyanov, 1978). Taking into account that zirconium has sole stable fluoride 
- ZrF4, we estimated the possibility of preservation of the initial chemical form of a molecule 
as tetra fluoride after decay of a parent nucleus 95Zr and formation on its place of 95Nb 
nucleus.  
The energy of the exited molecule, which can be spent on break of the chemical binding, is 
equal: 
R
B
R
M
E E
M M
=
+
 
where Е is recoil energy, Ǻ is mass of the recoil atom, MR - mass of the rest of molecule. 
0.44E will be spent on break of the chemical binding for a molecule ZrF4, i.e. about a half of 
95Zr recoil energy.  
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At β--decay of 95Zr basically two groups of β--particles with average energies of 121 and 110 
keV (Burrows, 1993) are formed. Recoil energy of 95Nb for β--particles with energy 121 keV 
makes 0.77 eV and for 110 keV – 0.69 eV. Besides at decay of 95Zr the Ǆ-quanta with energy 
about 750 keV are emitted. Thus the recoil energy of 95Nb will make 3.2 eV.  
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Fig. 3. Distribution of 95Zr and 95Nb activities on depth of graphite sample contacted with 
salt melt in the reactor MSRE core (Kirslis & Blankenship, 1969) 
As the binding energy of atoms in molecules is 2-5 eV (Nesmeyanov, 1978), in most cases of 
95Zr decay in a molecule 95ZrF4 the formed new atom 95Nb will be kept in the chemical form 
of the parent compound, i.e. as a molecule 95NbF4. The further fate of niobium tetra fluoride 
95NbF4 is determined by thermodynamics and radiation-chemical processes in molten salt 
fuel. In the reactor γ-field formation of niobium pent fluoride 95NbF5 is possible, which at 
temperature ≈600oC will be in gas form (Тboiling = 234oC), and at presence of the phase border 
“liquid – gas” it will leave fuel melt, penetrating, including, into open gas pores of graphite, 
which is in contact with molten salt fuel. The boiling temperature of zirconium fluoride is 
Тboiling = 9120ǿ, that is much higher than the fuel temperature. Therefore 95ZrF4 does not 
enter gas bubbles and, accordingly, does not penetrate into pores of graphite that explains 
significant difference of 95Zr and 95Nb contents in graphite.  
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In our opinion, the observed experimental results can be explained by formation and exit of 
easily volatile fluorides of noble metals Mo, Nb, Te from molten salt fuel to the gas phase. In 
detail the mechanism of 99Mo exit from molten salt fuel is considered in (Zagryadsky et al., 
2008; Menshikov & Chuvilin, 2008).  
The proposed radiochemical model of “noble” metals exit from fluoride fuel in a gas phase 
assumes, that chemical processes in fuel LiF-BeF2-UF4 vary sharply in the field of an ionizing 
radiation and are determined by a number of active particles - a complex ion BeF42,  radicals 
4
BeF
- , 3
2 8
Be F
-  and a number of other ions. The fragment molybdenum formed in molten-salt 
fuel at uranium fission exists in the melt mainly in the form of complex ions, such, for 
example, as
2
5
-
MoF . Reacting with ions 
3
2 8
-
Be F  within characteristic time τ ≈ 3⋅10-4 s, 
molybdenum ions can form at temperature ≈ 600oC volatile fluorides MoF4, MoF5, MoF6 
which, being near to borders with a gas phase will leave the melt. Due to presence in a gas 
phase of radiolitic fluorine, molecules 99MoF4, 99MoF5 are oxidized to a higher fluoride 
99MoF6 which is delivered by helium flow into catching system along transport 
communications. 
3.2 Advantages and possible variants of realization of fragment 
99
Mo production on 
the basis of molten salt nuclear fuel  
Basing on the results of experiments performed within the framework of the research 
program at the reactor MSRE and the hypothesis of the mechanism of 99Mo exit from molten 
salt fuel, we proposed a new way of fragment 99Mo production, using a spontaneous (or 
stimulated by bubbling of fuel with inert gas) exit of fragment 99Mo from molten salt fuel to 
the gas phase. For the first time this idea was mentioned in (Chuvilin & Zagryadsky, 1998).   
The aggregate condition of fuel on the basis of Li, Be and U fluorides allows to take 99Mo, 
89Sr, 133Xe from salt melt selectively, leaving 235U, and the basic group of fragment elements. 
As a result inherent for solid fuel systems radiochemical processing of the irradiated 
uranium is excluded, what at the end should result in reduction of highly active waste and 
of the flow of fission materials in the technological process. 
Principally the process of 99Mo production in a research reactor can be organized as follows 
(Chuvilin & Zagryadskiy, 1997). One of fuel assemblies of the reactor core is replaced with a 
loop facility filled with molten salt fuel, attached to a gas contour. As a result of 235U fission, 
in the salt melt 99Mo is generated, which moves to the salt - gas border and passes to the gas 
phase above the salt melt surface in form of fluorides and aerosols. 99Mo removal can be 
intensified by bubbling of helium or argon through salt. 
The collected in free volume of the loop system gas-aerosol fraction is removed by purge of 
the cavity with inert gas. The gas - carrier containing aerosols and volatile fluorides of 
molybdenum enters the catching system, which can be realized as a set of filters, chemical 
sorbents or freezing traps. Cleaned from fragment elements, inert gas recirculated in the 
loop system. For 99Mo removal, the filters periodically are directed to radiochemical 
processing. Accompanying molybdenum fragment elements deposited in the catching 
system are utilized after an appropriate procedure of extraction. The basic scheme of 
fragment 99Mo production in the molten salt reactor is shown in Fig. 4. 
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The possible design solutions of the loop system will be determined by the technology of 
99Mo removal from molten salt fuel. At the first stage of its introduction it is expedient to use 
elementary devices that will allow checking up the basic technical decisions, investigating 
radionuclide purity of the product, estimating economic parameters of the proposed way of 
99Mo production.  
 
Fig. 4. Scheme of fragment 99Mo production in a molten salt reactor 
3.3 Experimental ampoule loop system “RAMUS” 
For demonstration of physical practicability of the proposed new technology of 99Mo 
production, in the research reactor IR-8 of the NRC “Kurchatov Institute” experimental 
ampoule loop system “RAMUS” with molten salt fluoride fuel is created, where the process 
of 99Mo production will be realized according to (Chuvilin & Zagryadskiy, 1997). It is 
planned to determine the efficiency of 99Mo extraction from fuel, possibility of transporting 
molybdenum fluoride compounds from the reactor core to the accumulating zone for 
extraction from the gas – carrier flow, and other parameters. Besides that it is planned to 
produce as well two other accompanying radioisotopes of medical purpose: 89Sr, 133Xe in the 
loop system “RAMUS”. 
The loop system “RAMUS” will be placed in the beryllium reflector of IR-8 having neutron 
flux ≈1013 n⋅cm-2⋅s-1. The loop system has the following characteristics: 
Molar structure of fuel composition, %   66LiF-33.9BeF2-0.15UF4 
Enrichment by isotope 235U, %    90  
Volume of salt, cm3     450  
Power of reactor IR-8, MW    8  
Heat generation in fuel salt, kW    3.2  
Range of salt working temperatures, oC   613 - 680 
The basic scheme of the ampoule part of the loop system “RAMUS” is shown in Fig. 5. The 
radioisotopes 99Mo, 89Sr, 133Xe will be evacuated from molten salt fuel by bubbling of melt 
with helium. After passage of gas-carrier along the communications and filters, in which 
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decay and depositing of short-lived fission products take place, the target radioisotopes are 
caught in depositing devices, from which they are extracted subsequently.  
During design of the loop system "RAMUS" some technical decisions have required to be 
experimentally substantiated. In particular, the data on formation and carrying over of 
aerosol particles in the process of molten salt bubbling by inert gases and spontaneous 
thermocondensation of salt component vapors are practically absent in the literature. At 
bubbling the large interphase surface on “liquid-gas” border is created that promotes an 
intensification of mass-exchange processes, and also a more complete chemical interaction of 
gases with liquids. 
The experiments on formation and carrying over of aerosol particles by helium in the 
process of molten salt fuel bubbling were performed to make more precise the parameters of 
the unit “RAMUS”. The regime of the vertical bubble flow in molten salt 66LiF-34BeF2 was 
investigated at temperature 530-630oC. The experiments are carried out on a model 
installation reproducing the dimensions of the ampoule “RAMUS”. Weight and height of 
the salt melt made 900 g and 450 mm, respectively. For creation of the gas bubble flow, a 
tube was immersed in the salt melt, on which bottom end cylindrical sprayers with face or 
lateral holes were installed. 6 types of sprayers were tested. The stabilized helium flow rate 
varied in the range of 1.5-4.5 cm3 s-1.  
The rate of carrying over of aerosol particles was determined with help of the photometer 
FAN-A. Besides that the aerosols were taken out on filters and then the deposit was 
weighted and analyzed by ICP-AES and DTA-TDA methods.  
Foam was observed on the liquid surface in the experiments with bubbling of the salt melt 
by helium. It was possible to get the minimal height of the foam layer – 15-18 mm with the 
sprayer of three holes ∅=0.5 mm, L = 0.5 mm located uniformly on the circle. The mass 
concentration of aerosol particles did not exceed 100 mg⋅m-3, and the rate of their carrying 
over - 0.1 µg⋅s-1. The size distribution of aerosol particles has appeared bimodal. The first 
mode (superfine aerosol, average particle diameter ≈0.05 microns) is caused by spontaneous 
thermocondensation of salt components vapors at their cooling from 630oǿ to 60oǿ. 90÷95 
percents of aerosol particles mass consist of beryllium difluoride. That is because BeF2 
vapors pressure at temperature 6300ǿ more than 50 times exceeds LiF vapors pressure.  
The second mode of submicron aerosol is caused by collapsing of bubbles on the boundary 
surface “foam – gas” and corresponding dispersion of liquid. The diameter of particles taken 
out from an ampoule does not exceed 4 microns, at average diameter 0.5 microns. Their 
chemical structure coincides with the structure of the salt melt. It means that the carrying 
over of salt components in form of aerosols at bubbling of melt is determined by dispersion 
of liquid at collapsing of bubbles on the surface of two phase boundary, and the 
contribution of BeF2 superfine particles generated at vapors spontaneous 
thermocondensation makes less than 5% of weight.  
The received experimental results have allowed making a conclusion that for the planned 
term of the loop system "RAMUS" operation in the reactor IR-8 channel the convective 
carrying over of salt components in form of vapors and aerosols will be negligible small and 
will not influence gas-dynamic characteristics of communications and the gas flow filtration 
system of the loop system.  
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Fig. 5. General scheme of the ampoule part of the loop system “RAMUS” 
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In other series of the experiments, the possibility of MoF6 loss at its transport along 
technological communications of the loop system was studied depending on temperature. 
Sorption of MoF6 from the gas mixture flow (He + MoF6) with the contents of molybdenum 
hexafluoride in the range 1012 - 1013 cm-3 on granulated NaF was also investigated. The 
content of MoF6 in the gas mixture corresponds to the calculated concentration of fragment 
molybdenum in the loop system "RAMUS". The infra-red Fourier-spectrometer FSM-1202 is 
used for MoF6 measurement in the gas mixture. The experiments are carried out for the 
middle and near infra-red areas of the spectrum, with use of multirunning flask with the 
optical way 4.8 m long, which has allowed measuring MoF6 concentration down to 1012 cm-3. 
The measurements have shown that deep extraction of MoF6 from the gas flow takes place 
even at high flow rates of the mixture up to 10 cm3⋅s-1.  
The process of MoF6 desorption from the sorbent surface becomes noticeable at temperature 
100oC. However, as in reactor conditions the temperature at location of the column with 
sorbent will not exceed 60°C, the effect of MoF6 desorption in the loop system “RAMUS” 
could be neglected. The measurements of MoF6 losses during its transport along metal 
communications specially prepared in fluoride atmosphere have shown that they are within 
uncertainty limits of the spectrometer FSM-1202, and the loss of target product could be 
neglected.  
Thus, the carried out pre-reactor experiments have allowed estimating a number of 
technological parameters of the loop system “RAMUS”, choosing the optimal design of 
pneumatic sprayers and the regime of molten salt bubbling, predicting possible losses of 
MoF6 at its transport along gas communications of the loop system. 
4. Production of 
99Мо in solution reactors 
The reactor is named “solution” if its fuel is in the form of water solution of uranyl-sulphate 
UO2SO4 or uranyl-nitrate [UO2(NO3)2] (Kolesov, 1999). At production of 99Mo in the solution 
reactor, the necessity of target manufacturing and their radiochemical processing disappears. 
All the reactor fuel is a target. 99Mo is taken from solution by sorption on special sorbent.  
Russell Ball (companies Babcock & Wilcox and Ball Systems, the USA) has proposed a 
design of the liquid homogeneous reactor MIPR (Medical Isotope Production Reactor) for 
production of radioisotopes, in particular 99Ǻо (Ball, 1999). This reactor can work on 
uranylnitrate solution in water with low-enriched 235U (to 19 %) as fuel composition. At 
power of 200 kW it is capable to produce by estimations up to 2000 Ci of 99Ǻо a day. The 
proposed design of a reactor and its characteristics allows receiving the permission to its 
placing even in the centre of big cities. The power of a solution reactor is more than 10 times 
less than of a traditional research reactor and demands hundreds times smaller amount of 
235U for production of equal amount of 99Ǻо. According to estimations, building and 
physical start-up of a reactor will take 36 months with the total cost from 6 to 26 million US 
dollars. 
4.1 Production of fragment 
99
Mo on basis of solution reactor ARGUS 
“Argus” is a thermal homogeneous solution reactor, operating at stationary power up to 20 
kW in the NRC “Kurchatov Institute”. Water solution of uranylsulphate by volume 21.1 l 
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with uranium concentration 81.3 g/l and enrichment by 235U 90 % (Pavshouk & Chuvilin, 
2005; Afanasev et al., 1986) is used as fuel.  
The fuel solution is located in the case - a welded cylinder with a hemispherical bottom and 
a flat cover in which a cooling coil is located. Vertical “dry” channels are placed in the case: 
central and two symmetric peripheral channels in which control and safety rods are located. 
The reactor case is surrounded by a lateral and bottom face graphite reflector. Gaseous 
radiolysis products of fuel solution are regenerated by means of the system including a 
catalytic recombiner, which together with the case forms a tight system excluding leak of 
fission products to the environment. The recombination system is based on the principle of 
natural circulation of the gas mix along the contour. The solution type of the reactor 
provides conditions of the maximum safety which is guaranteed by the big negative 
reactivity effect and the optimum concentration of uranium in  solution, leading to self-
regulation of the reactor facility. 
Since the middle of the 90s years the National Research Centre ”Kurchatov Institute” has 
been working out a technology and creating a demonstration nuclear-technological complex 
of fragment 99Ǻо production on the solution reactor “Argus”. The aggregate state of the 
reactor “Argus” fuel allows 99Ǻо extraction directly from fuel solution without influence of 
structure and characteristics of the reactor core. For that, after reactor operation on power 
solution is pumped through special sorbent on the basis of titanium oxide which provides 
the first stage of 99Ǻо extraction from all mass of fission products. Thus uranium is not 
absorbed, and fuel solution completely comes back to the reactor case. All amount of the 
uranium which has undergone fission reaction, necessary for maintenance of reactor power, 
is spent for production of the target isotope.  
This newest technology of 99Ǻо production allows lowering the necessary reactor power 100 
and more times as compared to the traditional technology that not only results in reduction 
of radioactive waste production, but also supposes reactor locating in the occupied areas 
and promotes solving the licensing problems. Thus efficiency of 235U use comes practically 
to 100 % while in target technologies only 0.4 % of 235U are spent for getting the product, and 
its other part after target processing, as a rule, goes to waste (Starkov, 1996). The necessity of 
uranium targets manufacturing is, besides, excluded. The developed technology allows to 
solve an actual problem of uranium enrichment reduction in production of 99Ǻо and to 
eliminate public concern in connection with non-proliferation problem. The reactor which 
core is water uranylsulphate solution is used for accumulation of 235U fission fragments. 
Thus the yield of fragment 99Ǻо per fission of 235U makes 6 %. Accumulation of 99Ǻо in the 
core during the reactor operation on power of 20 kW is shown in Fig. 6. 
For demonstrating the practicability of 99Ǻо extraction technology directly from fuel 
solution, the demonstration experimental complex of the reactor “Argus” presented in Fig. 7 
and including a reactor loop, transportation means and hot cells equipment for purifying 
99Ǻо from fission products has been designed and put into operation.  
As a result of reactor experiments the possibility of 99Ǻо extraction from reactor solution 
fuel has been shown for the first time, and also the following technological process has been 
developed. The reactor “Argus” operates at power within 5 days. After some endurance, the 
fuel solution is pumped through sorbent within 3-6 hours. For returning of the rests of fuel 
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solution into the reactor case the reactor loop together with the sorption column is washed 
out by the condensate which has been accumulated in a system of radiolysis products 
regeneration during power operating time of the reactor. Then the column is remotely 
placed in a transport container and goes to hot cells, where after sorbent washing by acid 
solutions radionuclide 99Ǻо is desorbed with alkali. For getting demanded radionuclide 
purity two stages of purification with help of refinery columns filled with the same sorbent 
of type “Thermoxid” are taken. 
 
 
Fig. 6. Activity of 99Ǻо in the core depending on reactor operating time 
 
 
Fig. 7. Transport-technological scheme of demonstration complex at reactor “Argus” 
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Using the created demonstration equipment reactor experiments are performed on 
production of 99Ǻо samples and working out of solution technologies. Quality certification 
of the samples was performed in Europe (Institute of radioactive elements, Belgium), and in 
the USA (Argonne National Laboratory) where the impurity content in the sample more 
than 10 times less than in the international requirements (see table 4) was confirmed. The 
maximum activity of samples made ~ 10 Ci. 
On the basis of 99Ǻо produced in the solution reactor “Argus”, generators of 99mТс with the 
standard column filled with sorbent of type “Thermoxid” have been made. Eluted 99mТс has 
been investigated on injection suitability in State Scientific Center “Institute of Biophysics” 
of the Russian Federation and has received a good rating as for radionuclide purity, and 
absence of macro impurity of stable elements (manganese). 
 
 
Nuclide 
European 
requirements 
Results of the samples analyses 
IRE (Belgium) ANL (USA) 
ǂ-activity 
ǂ/99Mo 
 
<1.0⋅10-9 
 
1.4⋅10-10 
 
< 7.1⋅10-10 
ǃ-activity 
89Sr/99Ǻо 
90Sr/99Ǻо 
 
<6.0⋅10-7 
<6.0⋅10-8 
 
6.4⋅10-9 
6.4⋅10-10 
 
1.2⋅10-8 
7.8⋅10-11 
γ- activity 
131I/99Ǻо 
103Ru/99Ǻо 
 
<5.0⋅10-5 
<5.0⋅10-5 
 
1.1⋅10-5 
0.9⋅10-6 
 
4.2⋅10-7 
1.4⋅10-7 
Others γ-, β- 
(β-,γ-)Σ/99Ǻо 
132Te/99Ǻо 
133I/99Ǻо 
125Sb/99Ǻо 
 
 
<1.0⋅10-4 
 
<1.0⋅10-4 
4.4⋅10-5 
3.4⋅10-7 
2.7⋅10-7 
 
<3.8⋅10-7 
8.9⋅10-8 
- 
2.1⋅10-7 
Table 4. Results of 99Ǻо samples quality analysis 
4.2 Technology of radionuclide 
89
Sr production in the solution reactor 
One of the most effective ways is production of 89Sr from uranium fission products, but 
formation of impurity 90Sr makes impossible practical application of this way when uranium 
targets are used. The solution reactor type gives a unique possibility of solving this problem. 
The method of fragment radionuclide 89Sr extraction is based on a possibility during fission 
reaction in nuclear fuel of solution reactor to influence the genetic predecessors of a target 
radioisotope resulted in nuclear transformations of fission fragments in a decay chain of 
elements with the mass number 89: 89Se→89Br→89Kr→89Rb→89Sr. The earlier experimental 
researches have shown that practically all long-living isotopes of krypton and xenon leave in 
the gas phase of solution reactors (Loboda et al., 1989). The basic decay chains of the fission 
products, leading to formation of strontium radioisotopes with a half-life period of gaseous 
predecessors more than 1 second, are presented in Fig. 8. 
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Apparently from consideration of the basic decay chains leading to formation of radioactive 
strontium isotopes, the half-life period of the gaseous predecessor (89Kr) of a target 
radionuclide 89Sr makes 3.2 minutes, and the half-life period of a gaseous predecessor (90Kr) 
of the main impurity radionuclide Sr90 is essentially less and makes 33 s. Using this 
circumstance, in the isolated volume of a gas after corresponding endurance it is possible to 
reach demanded value of the activity ratio of target gaseous predecessors and impurity 
strontium radionuclides, and then to pump over the gas mix through filters in accumulating 
volume in which after decay of predecessors 89Sr will accumulate  (Loboda et al., 1989; 
Abalin et al., 2000). 
An experimental loop system consisting of a closed technological loop with rotation pumps, 
valves and vacuum–tight connecting units was used for taking gas samples from the reactor 
free volume. The hydraulic scheme of the experimental installation is shown in Figure 9. 
 
 
Fig. 8. Decay chains of fission products with atom masses 89 and 90 
The experiments confirming the possibility of 89Sr extraction from fuel solution of the 
reactor “Argus” were performed under the following scheme. The reactor operated at 
power from 5 to 20 kW within 20 minutes. Then after endurance within 5-6 minutes the gas-
air mix was pumped over through a column filled with Rashig rings. The reactor loop 
mentioned above was used. Pumping time of the gas mix was 5 minutes, which is enough 
for filling the column. The columns were removed after 2-3 days of gaseous fission products 
decay. In the laboratory the aggregate taken from the column was washed out with solution 
of hydrochloric acid for extraction of 89Sr and some accompanying fission products. 
A series of experiments for confirmation of fragment 89Sr production using exit of the 
gaseous predecessor 89Kr from fuel solution was performed. Samples of 89Sr chloride of high 
radionuclide purity are got in which 90Sr impurity content has made less than 5·10-4 %. The 
typical content of the produced 89Sr chloride solution is given in Table 5.  
With the obtained experimental estimations of 89Sr yield in a solution reactor we can 
compare the specific productivities of reactors BR-10 (Russia, Obninsk) (Zvonarev et al., 
1997), BOR-60, BR2 (Koonen, 1999).) with “Argus” reactor, normalized to the target mass 
and reactor power. For the sake of comparison, we accept the mass of 235U in the solution 
equal  to 1600 g, as a target. Table 6 shows specific yields of 89Sr in various reactor 
installations.  
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Fig. 9. Scheme of reactor “Argus” with experimental loop. 1 – reactor core; 2 – system of 
catalytic regeneration; 3 – accumulator of condensate; 4 - heat exchanger; 5 – catalytic 
recombiner; 6 – valves; 7 – sorption column; P1, P2 – pumps. 
 
Radionuclide 
Activity, relative units. 
ǻЕǾА MKF-F MKF-U 
Sr-89 1 1 1 
Cs-137 1.2·10-2 - - 
Ba-140 2.3·10-2 4.5·10-4 4.5·10-6 
Ce-141 5.4·10-4 - - 
Table 5. Typical content of the produced 89Sr chloride solution 
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Specific yield of 89Sr, ǺBq/g/kW 
BR-10 BOR-60 BR2 “Argus” 
7.4·10-3 0.01 0.4 45.0 
Table 6. Specific yields of 89Sr in various reactor facilities 
The advantage of the 20 kW solution reactor is obvious and undeniable. The expected 
“Argus” reactor productivity of (1.5-1.8)·103 GBq of 89Sr a year is comparable with that of 
the 60-MW BOR-60 Reactor (≈ 4·103 GBq/y). However, it is worth noting that 89Sr in a 
solution reactor is a byproduct from its “main” production of medical 99Mo/99Tc. The target 
radionuclide separation occurs spontaneously; a majority of fission fragments remains in the 
fuel, and the buildup of radioactive waste with the new technology is very low. The 
separated impurity radionuclides 133Xe and 135Xe can also be used in medicine, while 137Cs is 
a valuable radionuclide for technical applications.  
The unique properties of the solution reactor fuel open the doors for this type of nuclear 
installations to the nuclear medicine industry. Separation of radionuclides directly from fuel 
solution allows using the low power (50 kW) reactor for production of 99Mo with the 
minimum yield of 1.85⋅104 GBq/day, 700 GBq/week of 133Xe, as well as a number of other 
valuable radionuclides (Burrows, 1993; Zagryadsky et al., 2008).  
So, the new method for medical 89Sr production in the reactor with solution fuel is proposed 
which is characterized by simplicity, high production efficiency and low buildup of 
radioactive waste. The main advantages of the new technology were validated by numerous 
experiments. Basic features of the method are as follows: 
• the mechanism for 89Sr delivery to the sorption volume of the “Argus” reactor 
experimental loop is based on transport of gaseous 89Sr predecessor – radionuclide  
89Kr;  
• the radionuclide impurity composition of 89SrCl2 solution includes elements with 
nuclear masses 137, 140 and 141, which have gaseous elements in their decay lines;  
• filtration of the gas flow with mechanical aerosol filters reduces the content of 
radionuclide impurities 102-103 times;  
•  cleaning of 89Sr chloride solution in chromatographic columns with DOWEX-50×8 or 
Sr-Resin ensures full removal of 137Cs from the solution and significant reduction of 
140Ba/140La impurity; 
• 90Sr impurity in 89SrCl2 solution was not detected with the measuring instruments 
within the sensitivity limits of (≈5⋅10-4 %).  
5. Conclusions 
The key problem of modern medical radionuclide production in research nuclear reactors - 
considerable amount of a highly active waste and use in technology of highly-enriched 
uranium - can be solved by transition to use of homogeneous liquid nuclear fuel enriched by 
isotope of uranium 235U less than 20 %. It is known (Basmanov, E. et al., 1998), that 
conversion traditional «target» technology of fragment radioisotopes production from HEU 
to LEU in a target cycle not only does not solve a problem of a radioactive waste (the yield 
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of fission products per unit 99Mo activity is the same), but also aggravates it: the amount of 
the irradiated uranium, the radioactive waste accompanying processing of more uranium 
for the same 99Mo yield, both accumulation of 239Pu and other transuranic elements increase 
in times. That increases the product cost and difficulty of disposal. A target turnover cycle of 
fission materials is absent in the proposed concept of medical isotopes production. 
Therefore, on the one hand, the overwhelming part of the waste connected with fission of 
uranium appears "locked" in a reactor core or a loop installation, and, on the other hand, 
there is no problem of fission materials proliferation in a target cycle. The question of 
conversion of the considered reactors with liquid fuel from HEU to LEU does not concern 
actually technology of medical isotopes production, and should be considered within the 
general strategy of nuclear reactors safety. Technical possibility of such conversion does not 
call doubts. 
The accumulated operational experience with solution and molten salt fuel, presence of the 
developed experimental base provide a possibility for performing a broad spectrum of 
technological researches directed on creation and realization of new methods for production 
of radionuclides and radiopharmaceuticals for nuclear medicine. 
Carried out in the NRC “Kurchatov Institute” model experiments at the solution reactor 
“Argus” have confirmed basic provisions of the new law-waste technologies of 99Ǻо and 
89Sr production. 
This newest technology of the most important medical radionuclide production allows to 
lower necessary power of a reactor 100 and more times comparing to traditional technology 
that not only leads to decrease in total radioactive wastes of production, but also supposes 
placing the reactor in the occupied areas and promotes solving the licensing problems. The 
efficiency of 235U use comes practically to 100 % while traditional target technologies use 
only 0.4 % of 235U for reception of the final product, and other part of uranium after target 
processing, as a rule, goes to utilization.  
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